How to Help Your Patients Save Money on Tetrabenazine: A Provider's Guide to Savings Programs

For neurologists and clinicians managing Huntington's disease, Tetrabenazine's cost is one of the most pressing barriers to sustained adherence. With a retail list price exceeding $4,000 per month, even insured patients can face significant out-of-pocket burdens. This guide provides a practical framework for helping your Huntington's disease patients navigate the full landscape of Tetrabenazine savings programs in 2026.

Understanding the Price Landscape

Tetrabenazine's cost structure varies dramatically depending on how a patient pays:

Retail list price (brand Xenazine or generic): $4,000–$4,400 per month for 60 tablets without any discount

With GoodRx or SingleCare coupon: As low as $60–$65 per fill for generic tetrabenazine (99%+ discount from list price)

With commercial insurance + specialty tier: Variable; often $50–$200+/month copay depending on plan and deductible status

With Medicare Part D (2025+ OOP cap): Maximum $2,000/year out-of-pocket under the Inflation Reduction Act's Medicare Part D cap

Program 1: Prescription Discount Coupons (GoodRx, SingleCare)

For uninsured patients or those in high-deductible phases of their insurance, prescription discount programs offer the most immediate relief. GoodRx and SingleCare both show generic Tetrabenazine available for as low as $60 per fill at participating pharmacies — a savings of over $3,900 per fill from list price.

Important clinical consideration: GoodRx and SingleCare coupons cannot be combined with insurance. Patients must choose one or the other at the time of fill. If a patient's insurance copay is lower than the coupon price (which is rare for specialty drugs at list), they should use insurance. In practice, the $60 GoodRx price is often lower than specialty drug copays until the patient's deductible is met.

Program 2: Lundbeck Patient Assistance Program

Lundbeck, the originator of Xenazine (brand tetrabenazine), offers a patient assistance program (PAP) for eligible patients who are uninsured or underinsured. Key details for providers:

Typically requires income verification and documentation of lack of adequate insurance coverage

Applications require a provider signature — build this into your practice workflow for HD patients

PAP provides brand Xenazine at reduced or no cost for qualifying patients

Contact Lundbeck Patient Access Services or visit Lundbeck.com for current program details

Program 3: NeedyMeds and RxAssist Directories

NeedyMeds (needymeds.org) and RxAssist (rxassist.org) maintain comprehensive, up-to-date databases of all available manufacturer PAPs, state pharmaceutical assistance programs, and charitable foundations offering drug assistance. These are valuable reference resources for your practice's care coordinators or social workers navigating Tetrabenazine access for complex patients.

Program 4: Medicare Part D — 2025/2026 Out-of-Pocket Cap

For Medicare-enrolled HD patients, the most significant change in recent years is the Inflation Reduction Act's Medicare Part D out-of-pocket cap. Starting January 1, 2025, Medicare Part D enrollees pay no more than $2,000 per calendar year for covered prescription drugs. This cap is a substantial improvement for Tetrabenazine patients, who previously could face catastrophic cost-sharing phases with no annual ceiling.

Counsel Medicare patients that:

Prior authorization is still required for Tetrabenazine under Medicare Part D

The $2,000 cap resets each January 1

Extra Help (Low Income Subsidy) program is available for lower-income Medicare beneficiaries and can further reduce drug costs

Program 5: HDSA Financial Assistance Navigation

The Huntington's Disease Society of America (hdsa.org) offers social work support through HD Center of Excellence teams. HDSA social workers are specifically trained in navigating medication access and financial assistance for HD patients. For complex cases, a warm referral to an HDSA-connected social worker can be more effective than handling assistance navigation in-house.

Program 6: 90-Day Mail-Order Fills for Cost Savings

Many commercial insurance plans offer incentivized pricing for 90-day mail-order fills — typically equivalent to 2 copays instead of 3. For a patient on stable Tetrabenazine dosing, switching to 90-day mail-order reduces both cost and the access friction of monthly refills. Prescribe a 90-day supply once the patient is stable at their therapeutic dose.

How medfinder Supports Patient Access

When Tetrabenazine access issues arise — whether cost-related or availability-related — medfinder helps patients quickly locate pharmacies with stock and compare their fill options. Referring patients to medfinder.com/providers is a practical complement to financial assistance programs, ensuring patients can actually get their medication once cost barriers are addressed.

See also: Tetrabenazine Shortage: What Providers Need to Know in 2026 for availability and prescribing guidance.